In the PLASMA phase I trial, young plasma infusion in Alzheimer was safe and feasible, with no proven efficacy (small sample). ConfidenceSpeculative Level of evidence●●●●●○ Randomized clinical trial Observed inHuman MissionMap of aging (12 hallmarks) ConceptsAltered intercellular communicationYoung plasma infusionAlzheimer's disease